Victor M Castro1, Faith M Gunning1, Thomas H McCoy1, Roy H Perlis1. 1. Center for Quantitative Health, Massachusetts General Hospital, and Department of Psychiatry, Harvard Medical School, Boston (Castro, McCoy, Perlis); Research Information Science and Computing, Mass General Brigham, Somerville, Mass. (Castro); and Department of Psychiatry, Weill Cornell Medicine, New York (Gunning).
Abstract
OBJECTIVE: The authors sought to characterize the association between prior mood disorder diagnosis and hospital outcomes among individuals admitted with COVID-19 to six Eastern Massachusetts hospitals. METHODS: A retrospective cohort was drawn from the electronic health records of two academic medical centers and four community hospitals between February 15 and May 24, 2020. Associations between history of mood disorder and in-hospital mortality and hospital discharge home were examined using regression models among any hospitalized patients with positive tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). RESULTS: Among 2,988 admitted individuals, 717 (24.0%) had a prior mood disorder diagnosis. In Cox regression models adjusted for age, sex, and hospital site, presence of a mood disorder prior to admission was associated with greater in-hospital mortality risk beyond hospital day 12 (crude hazard ratio=2.156, 95% CI=1.540, 3.020; fully adjusted hazard ratio=1.540, 95% CI=1.054, 2.250). A mood disorder diagnosis was also associated with greater likelihood of discharge to a skilled nursing facility or other rehabilitation facility rather than home (crude odds ratio=2.035, 95% CI=1.661, 2.493; fully adjusted odds ratio=1.504, 95% CI=1.132, 1.999). CONCLUSIONS: Hospitalized individuals with a history of mood disorder may be at risk for greater COVID-19 morbidity and mortality and are at increased risk of need for postacute care. Further studies should investigate the mechanism by which these disorders may confer elevated risk.
OBJECTIVE: The authors sought to characterize the association between prior mood disorder diagnosis and hospital outcomes among individuals admitted with COVID-19 to six Eastern Massachusetts hospitals. METHODS: A retrospective cohort was drawn from the electronic health records of two academic medical centers and four community hospitals between February 15 and May 24, 2020. Associations between history of mood disorder and in-hospital mortality and hospital discharge home were examined using regression models among any hospitalized patients with positive tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). RESULTS: Among 2,988 admitted individuals, 717 (24.0%) had a prior mood disorder diagnosis. In Cox regression models adjusted for age, sex, and hospital site, presence of a mood disorder prior to admission was associated with greater in-hospital mortality risk beyond hospital day 12 (crude hazard ratio=2.156, 95% CI=1.540, 3.020; fully adjusted hazard ratio=1.540, 95% CI=1.054, 2.250). A mood disorder diagnosis was also associated with greater likelihood of discharge to a skilled nursing facility or other rehabilitation facility rather than home (crude odds ratio=2.035, 95% CI=1.661, 2.493; fully adjusted odds ratio=1.504, 95% CI=1.132, 1.999). CONCLUSIONS: Hospitalized individuals with a history of mood disorder may be at risk for greater COVID-19 morbidity and mortality and are at increased risk of need for postacute care. Further studies should investigate the mechanism by which these disorders may confer elevated risk.
Entities:
Keywords:
Bipolar and Related Disorders; Coronavirus/COVID-19; Depressive Disorders
Authors: Alain K Koyama; Emilia H Koumans; Kanta Sircar; Amy M Lavery; Jean Y Ko; Joy Hsu; Kayla N Anderson; David A Siegel Journal: Emerg Infect Dis Date: 2022-07 Impact factor: 16.126
Authors: Nicolas Hoertel; Marina Sánchez-Rico; Pedro de la Muela; Miriam Abellán; Carlos Blanco; Marion Leboyer; Céline Cougoule; Erich Gulbins; Johannes Kornhuber; Alexander Carpinteiro; Katrin Anne Becker; Raphaël Vernet; Nathanaël Beeker; Antoine Neuraz; Jesús M Alvarado; Juan José Herrera-Morueco; Guillaume Airagnes; Cédric Lemogne; Frédéric Limosin Journal: Biol Psychiatry Glob Open Sci Date: 2022-01-04
Authors: Marc De Hert; Victor Mazereel; Marc Stroobants; Livia De Picker; Kristof Van Assche; Johan Detraux Journal: Front Psychiatry Date: 2022-01-13 Impact factor: 4.157
Authors: Katherine M Schultz; Pamela Blair Miller; Lisa Stancill; Lauren M DiBiase; Shelley Ashcroft; Barbara-Ann Bybel; Gary J Gala; Kenan M Penaskovic; Paul Perryman; Lisa Teal; David J Weber; David Witek; Michael N Zarzar; Emily Sickbert-Bennett Journal: Am J Infect Control Date: 2022-02-11 Impact factor: 4.303
Authors: Roy H Perlis; Katherine Ognyanova; Mauricio Santillana; Jennifer Lin; James Druckman; David Lazer; Jon Green; Matthew Simonson; Matthew A Baum; John Della Volpe Journal: JAMA Netw Open Date: 2022-01-04
Authors: Eva Z Reininghaus; Mirko Manchia; Nina Dalkner; Nina Bonkat; Alessio Squassina; Isabel Hodl; Eduard Vieta; Andreas Reif; Tomas Hajek; Mikael Landén; Christoph U Correll; Jan Scott; Bruno Etain; Marcella Rietschel; Veerle Bergink; Monica Martinez-Cengotitabengoa; Lars Vedel Kessing; Andrea Fagiolini; Michael Bauer; Guy Goodwin; Ana Gonzalez-Pinto; Ralph W Kupka; Thomas G Schulze; Trine V Lagerberg; Ayşegül Yildiz; Chantal Henry; Gunnar Morken; Phillip Ritter; René Ernst Nieslen; Rasmus W Licht; Andreas Bechdolf; Ole A Andreassen; Frederike Tabea Fellendorf Journal: Eur Neuropsychopharmacol Date: 2021-09-10 Impact factor: 4.600